Pfizer launches Kovid-19 vaccine delivery trials in four US states. world News

Pfizer has launched a pilot delivery program for its experimental Kovid-19 vaccine in four US states, as the drugmaker seeks to address delivery challenges posed by its ultra-cold storage requirements.

The American drugmaker said Rhode Island, Texas, New Mexico and Tennessee were chosen for the program because of differences in overall size, population diversity, and vaccination infrastructure, as well as states in various urban and rural areas There is a need to reach people. Adjustment.

Pfizer said in a statement, “The four states involved in this pilot program will not receive vaccine supplements earlier than other states according to the quality of this pilot, nor will they be considered a difference.”

“We hope that the results from this vaccine delivery pilot will serve as a model for other US states and international governments as they prepare to implement effective Kovid-19 vaccine programs.”

A week ago, Pfizer released preliminary data on its vaccine developed with German partner BioNTech SE, which showed More than 90% effective.

Pfizer vaccines must be shipped and stored at -70 ° C (-94 ° F), well below the standard for vaccines of two to eight ° C (36–46 ° F).

Earlier on Monday, rival Modern Inc. said Its experimental vaccine was 94.5% effective A late-stage trial to prevent covid-19 based on interim data, raises the hope that vaccines against the disease may be ready for use soon. The modern vaccine does not require ultracold freezing, a factor that could prove to be a major advantage over Pfizer’s product.

Both Pfizer and Modern use a new technology called synthetic messenger RNA to activate the immune system against vaccine viruses.

Experts have raised concerns about the distribution challenges associated with Pfizer’s vaccine due to its special storage requirements.

An outbreak of optimism that a vaccine could soon control the coronovirus and the economic devastation it causes, the Dow Jones Industrial Average reached record levels for the first time in nine months on Monday.

Leading the way were stocks of companies that would benefit from their forced hibernation exit economy, such as airlines, movie theaters and banks.

Epidemic winning stocks that benefited from lockdown orders such as Amazon and Zoom Video Communications, as they no longer appeared to play only safe bets.

The Dow jumped 470.63 points or 1.6% to 29,950.44 points. It surpassed its earlier closing record of 29,551.42 in February, sending stocks beset by epidemic fears.

With Reuters and AP